Bladder cancer risk and genetic variation in AKR1C3 and other metabolizing genes.
about
Sulfotransferase genetic variation: from cancer risk to treatment responseAssociation between NQO1 C609T polymorphism and bladder cancer susceptibility: a systemic review and meta-analysisQuality of life effects of androgen deprivation therapy in a prostate cancer cohort in New Zealand: can we minimize effects using a stratification based on the aldo-keto reductase family 1, member C3 rs12529 gene polymorphism?Putative EPHX1 enzyme activity is related with risk of lung and upper aerodigestive tract cancers: a comprehensive meta-analysisGenetic variation and antioxidant response gene expression in the bronchial airway epithelium of smokers at risk for lung cancer.The Activity of SN33638, an Inhibitor of AKR1C3, on Testosterone and 17β-Estradiol Production and Function in Castration-Resistant Prostate Cancer and ER-Positive Breast Cancer.Association of CYP1B1 L432V polymorphism with urinary cancer susceptibility: a meta-analysisAldo-keto reductase 1C3 is overexpressed in skin squamous cell carcinoma (SCC) and affects SCC growth via prostaglandin metabolism.Variation in AKR1C3, which encodes the neuroactive steroid synthetic enzyme 3α-HSD type 2 (17β-HSD type 5), moderates the subjective effects of alcoholQuantitative assessment of the influence of EPHX1 gene polymorphisms and cancer risk: a meta-analysis with 94,213 subjects.Sex hormone pathway gene polymorphisms are associated with risk of advanced hepatitis C-related liver disease in malesMolecular markers in sex hormone pathway genes associated with the efficacy of androgen-deprivation therapy for prostate cancerVariation in genes encoding the neuroactive steroid synthetic enzymes 5α-reductase type 1 and 3α-reductase type 2 is associated with alcohol dependence.A screening-testing approach for detecting gene-environment interactions using sequential penalized and unpenalized multiple logistic regressionQuantitative evaluation of aldo-keto reductase expression in hepatocellular carcinoma (HCC) cell lines.Pharmacogenetics of SULT1A1Cytochrome P4501A2 phenotype and bladder cancer risk: The Shanghai bladder cancer study.The association between NQO1 Pro187Ser polymorphism and bladder cancer susceptibility: a meta-analysis of 15 studies.Lack of association between polymorphisms in the CYP1A2 gene and risk of cancer: evidence from meta-analyses.Basal and Regulatory Promoter Studies of the AKR1C3 Gene in Relation to Prostate Cancer.Potential role of UGT1A4 promoter SNPs in anastrozole pharmacogenomicsBladder cancer SNP panel predicts susceptibility and survivalGenetic variants in urinary bladder cancer: collective power of the "wimp SNPs".Common genetic variants in the myeloperoxidase and paraoxonase genes and the related cancer risk: a review.CYP1A1 and GSTP1 gene variations in breast cancer: a systematic review and case-control study.Hypoxia triggers major metabolic changes in AML cells without altering indomethacin-induced TCA cycle deregulation.Genetic variation in the eicosanoid pathway is associated with non-small-cell lung cancer (NSCLC) survival.Environmental factors and risk of aggressive prostate cancer among a population of New Zealand men - a genotypic approach.Genotypes of CYP1A1, SULT1A1 and SULT1A2 and risk of squamous cell carcinoma of esophagus: outcome of a case-control study from Kashmir, India.Impact of nonsynonymous single nucleotide polymorphisms on in-vitro metabolism of exemestane by hepatic cytosolic reductases.Association between the CYP1B1 polymorphisms and risk of cancer: a meta-analysis.Association between the CYP1A2 polymorphisms and risk of cancer: a meta-analysis.Pharmacogenetics of aldo-keto reductase 1C (AKR1C) enzymes.Association between NAD(P)H:quinone oxidoreductase 1 rs1800566 polymorphism and risk of bladder cancer.Differentiation-associated urothelial cytochrome P450 oxidoreductase predicates the xenobiotic-metabolizing activity of "luminal" muscle-invasive bladder cancers.Associations between Rs4244285 and Rs762551 gene polymorphisms and age-related macular degeneration.The CYP1B1 Leu432Val polymorphism and risk of urinary system cancers.AKRs expression in peripheral blood lymphocytes from smokers: the role of body mass index.Association between the CYP3A4 and CYP3A5 polymorphisms and cancer risk: a meta-analysis and meta-regression
P2860
Q27027019-E86E21D2-4C59-4C5D-BEA3-078F130F3293Q28292318-BC0883FD-E767-426B-A18B-DD0DFE75C196Q28385758-CB63F045-1F96-4EB1-9594-00C7C0E3088BQ28741808-57386857-71BA-411E-BB09-1E084279A7FFQ33651055-7DCEEC14-F427-4EC9-A07C-F768B7F25D18Q33770742-643F3AE2-FD2E-4495-B008-3D1E702EE07FQ33792655-4349CED0-45CF-455E-816F-1E2FE98EC72DQ34016727-979209DF-04DD-43B9-8F66-47B5A1E6EEA8Q34054066-AE2F22F7-9BF4-4635-9B24-20031A28D1C5Q34306305-9D657A52-F075-4901-8A58-533A6B506D6CQ34426531-FDA318CC-8DCE-421E-9C0A-78869AA019B6Q34566518-2FAB3980-D845-4369-AC22-AEC6FBECA462Q34872888-6B429419-AAF1-4CDF-A732-AC56AA169A7BQ34988246-D5375C78-FD89-474C-A4D5-DF229A7551F4Q35171770-89824CB5-F5D2-4B94-9647-01D5454D373CQ35183173-0A6F4BC6-9061-482C-B8C4-D17C371F73D3Q35199390-B2CBFBB2-2E62-4A68-A9BD-E0AB1BA2E4D2Q35545080-2297C3F4-10E8-4EFC-8B99-03683572EE94Q35920271-8CA6703F-5766-453D-94F9-FB4FDB03709AQ36141651-CEAFCC83-F6B4-4A2B-98E7-45F849662141Q36717159-7CDE27D1-CE2B-4906-82F3-424D4F7F8F0EQ37390898-6E2BE27A-9AEC-4108-9C99-9A5498519075Q37850339-F86EF1A0-9945-442B-9DCD-3C8F445C7D79Q38061182-48EFFD68-09CA-4B2E-964C-BDC1918DCC59Q38627269-7C847F8F-D6D3-488F-B911-18D609783E76Q39649162-5DC5235D-4651-403C-A144-2A5382601849Q40124162-120820F3-0395-441C-B8E8-E7BB576675B4Q40311743-8340815E-A11F-450B-968C-70477A86C9FDQ41235678-999EB776-EED8-4EAA-B5FA-A294F1FA4D7FQ41630307-0C90DBEF-3685-4F07-A1B4-D616FB46E917Q41727091-7546DD0E-68D5-48EE-A9B1-949566CBEBFBQ41730140-FA9A80F8-F1E9-4412-8DFB-E8BFD3931659Q47965250-76D665A8-4384-44B0-9C11-E9A3909D8A28Q47967841-709BBF24-F946-4F2B-9562-40F98B35D85DQ48261416-3A7A9AF1-613B-4A51-991C-F10477A03F7BQ50949688-1FD09BD0-1992-45D2-9839-B0DD50411F85Q53134756-79D015B3-FD89-47E0-B282-CB7A34FF7300Q53266462-4EDBAD17-6059-46C5-88F4-F780DF0A030EQ57097002-0BFCB2B5-B7D4-4347-8898-960CD316D650
P2860
Bladder cancer risk and genetic variation in AKR1C3 and other metabolizing genes.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Bladder cancer risk and genetic variation in AKR1C3 and other metabolizing genes.
@en
type
label
Bladder cancer risk and genetic variation in AKR1C3 and other metabolizing genes.
@en
prefLabel
Bladder cancer risk and genetic variation in AKR1C3 and other metabolizing genes.
@en
P2093
P2860
P50
P356
P1433
P1476
Bladder cancer risk and genetic variation in AKR1C3 and other metabolizing genes.
@en
P2093
Alfredo Carrato
Consol Serra
Debra Silverman
Mustafa Dosemeci
Núria Malats
Reina García-Closas
Robert Welch
P2860
P304
P356
10.1093/CARCIN/BGN163
P407
P50
P577
2008-07-16T00:00:00Z